Immune pathways in esophageal and stomach cancer
Part of Cancer, Immune system & allergy clinical trials.
This study looks at how your immune system responds to esophageal or stomach cancer. If you are newly diagnosed and planning staging tests or surgery, researchers want to understand your immune pathways to find better ways to treat this cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You are having an endoscopy (OGD) to investigate symptoms like trouble swallowing, vomiting, reflux, anemia, bleeding, pain, or weight loss, or you have conditions like esophagitis, gastritis, GORD, or Barrett's esophagus.
- You have a confirmed diagnosis of esophageal or stomach cancer (adenocarcinoma or squamous cell carcinoma).
- This is your first diagnosis of this cancer (not a recurrence).
- You are either having staging tests (like laparoscopy or another endoscopy) or planning to have surgery to remove the cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system behaves in stomach or lower esophagus cancer before standard (planned) surgery. It may help researchers understand which immune features relate to outcomes and treatment response.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
This study looks at how often people who had surgery for esophageal or stomach cancer should have follow-up tests. It aims to find the best way to monitor you after treatment.
This research study uses medical records and imaging from patients with various esophageal conditions—from inflammation to cancer—to develop better diagnostic and prediction tools. Researchers want to understand what changes in the esophagus lead to cancer and how to catch it earlier.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
Hear when a new Oesophagogastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.